NCT04342338

Brief Summary

This is a novel project which incorporates clinic and community pharmacists in three aspects of the Patient-Centered Medical Home: pre-visit planning, pre-visit care team huddles, and chronic care management (CCM). Patients for the project are enrolled in the NEIFPC CCM program and have Greenwood pharmacy as their primary pharmacy. Community and clinic pharmacists will contribute to pre-visit medication reviews and document their drug therapy recommendations in a shared, templated note in the clinic EHR. NEIFPC pharmacists will attend pre-visit team huddles to relay drug therapy recommendations to the physician. Revenue from CCM services will be prorated and shared between Greenwood pharmacy and NEIFPC. The project will last 9 months. Primary aims are to describe the pharmacist pre-visit planning service, summarize the billing experience of a community pharmacist providing this service, and to describe the drug therapy interventions made by pharmacists.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 13, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

August 3, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

September 1, 2020

Status Verified

August 1, 2020

Enrollment Period

9 months

First QC Date

April 8, 2020

Last Update Submit

August 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Summary of Drug Therapy Interventions made by Pharmacists

    Summarize drug therapy interventions made by community and ambulatory care pharmacists for pre-visit team huddles with Family Medicine physicians.

    07/01/2020- 03/31/2021

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Medicare patient's who are enrolled in the CCM program at the Northeast Iowa Family Practice Center with Greenwood Pharmacy as their primary pharmacy.

You may qualify if:

  • Patient enrolled in Medicare
  • Patient enrolled in the Chronic Care Management (CCM) program at the Northeast Iowa Family Practice Center
  • Patient's primary pharmacy is Greenwood Pharmacy

You may not qualify if:

  • Patient not enrolled in Medicare
  • Patient not enrolled in CCM program
  • Patient's primary pharmacy is any pharmacy other than Greenwood Pharmacy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northeast Iowa Family Practice

Waterloo, Iowa, 50702, United States

Location

MeSH Terms

Conditions

Multiple Chronic Conditions

Condition Hierarchy (Ancestors)

Chronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2020

First Posted

April 13, 2020

Study Start

August 3, 2020

Primary Completion

April 30, 2021

Study Completion

April 30, 2021

Last Updated

September 1, 2020

Record last verified: 2020-08

Locations